Science|Business Database: Coronavirus Funding Opportunities

Contributions must improve treatment, diagnosis or the public health response to the COVID-19 epidemic.

Proposals must be appropriate to the emergency situation and, therefore, allow immediate implementation and start-up in the National Health System, with concrete, early results applicable to the current situation.

Projects should be able to be quickly implemented and focus on increasing supplies of products to deal with the pandemic, vaccines, improving COVID-19 treatment and diagnosis, and new public health measures.

Support to enable existing projects to address prevention, diagnosis, treatment, supply of critical resources and other issues facing the COVID-19 crisis.

Funding for innovative and low-cost solutions focused on COVID-19 diagnosis, treatment, epidemiology, PEE, and telehealth.

Research projects for potential treatments, techniques and datasets will be prioritised according to their impact on public health. Preference will be given to projects that plan to make their datasets publicly available and referenceable.

An invitation to contribute to the understanding of the COVID-19 epidemic in Bolivia and its impact on mental health, food security, the economy, and education.

Rapid access for groups who require instrument time for projects to discover more about the virus, vaccine, diagnostics or treatment.

Funding for existing PCORI-funded projects that wish to adapt or alter their original aims to produce useful knowledge or research related to COVID-19.

Accelerate the development of diagnostics and medical countermeasures for a rapid front-line response to protect and treat Canadians.

Proposals should include test kits, respiratory devices, protective equipment or mobile applications for detection, tracing, and information sharing, that can respond to the current emergency medical needs for Lebanon.

A call for proposals for better understanding of diagnosis, prevention and management of the virus

Research is to focus on vaccines and therapeutics; and on diagnostics, clinical investigations, anthropology investigations, and development of technologies, platforms or systems to accelerate the R&D of diagnostics.

Any aspect of coronavirus research. Applicants may request up to 300,000 francs for projects lasting up to 24 months. Bigger grants are conceivable, provided the applicant has good reasons for requesting a higher amount.

Funding for private and public institutions that can develop a COVID-19 diagnostics kit for Uruguay by May 2020.

Funding opportunity for all EIC-backed SMEs that can contribute to possible solutions to help combat the current pandemic and its consequences.

A call for proposals to accelerate development of diagnostics, vaccines, novel therapeutics and re-purposing of drugs

A special call specifically designed for COVID-19 and related respiratory viral infections to ramp up national R&D efforts for new antivirals, vaccines, and affordable diagnostics.

Development of antivirals as well as other types of therapeutics to address a rapid response to the current COVID-19 outbreak; therapeutics to address the current and/or future coronavirus outbreaks; diagnostics, ensuring rapid evaluation of candi

Funding for universities, technologists and researchers with innovative proposals, including seed funding, to provide solutions applicapel to the COVID-19 pandemic.